Clinical Trials Directory

Trials / Completed

CompletedNCT00283595

Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa

Effect of Supraphysiological rhGH on Bone Metabolism in Patients With Anorexia Nervosa

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
Female
Age
14 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Decreased bone strength is a serious medical problem present in many women with Anorexia Nervosa, or disordered eating. Women with weaker bones are more likely to suffer broken bones than women with normal bone strength. We are investigating whether a hormone that is naturally produced by the human body, called growth hormone, can help strengthen the bones of women with this type of disordered eating.

Detailed description

* Twelve week study * Eight visits, six of which can be conducted at your home physician's office * Two bone density scans * Hormonal and nutritional evaluations

Conditions

Interventions

TypeNameDescription
DRUGRecombinant Human Growth HormoneDosage increased in steps for first four weeks. Self injection qd x 12 weeks
DRUGPlacebo for Recombinant Human Growth HormoneAdministered as Arm 1, rHGH active Injection qd x 12 weeks Dosage increase over four weeks

Timeline

Start date
2006-01-01
Primary completion
2009-02-01
Completion
2009-02-01
First posted
2006-01-30
Last updated
2020-09-02
Results posted
2012-10-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00283595. Inclusion in this directory is not an endorsement.